MARLBOROUGH, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, a spatial proteomics leader, announced its reagent product roadmap today, featuring new ultrahigh-plex neurobiology panels for ...

Akoya Biosciences (AKYA) announced its reagent product roadmap, featuring new ultrahigh-plex neurobiology panels for human ...

Quanterix公司近日宣布，将以全股票交易方式收购空间生物学公司Akoya Biosciences。 两家公司在一份声明中表示，他们将把Akoya的空间生物学能力与Quanterix的生物标志物检测工具整合在一起，以实现对血液和组织中的蛋白标志物的超灵敏检测。 Quanterix公司总部位于 ...

在一项扩大市场影响力的战略举措中，目前市值3.64亿美元的Quanterix Corp (NASDAQ:QTRX)宣布收购Akoya Biosciences, Inc.，根据合并协议，Akoya将成为Quanterix的全资子公司。这一进展在最近向美国证券交易委员会提交的8-K文件中披露。

Akoya Biosciences announced a significant expansion of its product offerings with the introduction of new high-plex neurobiology panels for human and mouse applications, enhancing their recent ...

Akoya Biosciences (AKYA) and Argonaut Manufacturing Services, a contract development and manufacturing organization serving the biopharma and ...

To further its efforts in advancing spatial biology imaging, Marlborough-based biotech firm Akoya Biosciences has agreed to be acquired by Quanterix, a Billerica-based research corporation. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Quanterix (QTRX) and Akoya Biosciences (AKYA) announced a definitive merger agreement under which Quanterix will acquire Akoya in an all-stock transaction. The transaction is expected to generate ...

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian McKelligon has sold company shares valued at approximately $15,630, according to a recent SEC filing. The transactions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...